Regulations.gov document
Attachment 1 Galliprant grapiprant Tablets re Suitability Petition from Aurora…
Supporting & Related Material · FDA-2023-P-2347 · posted Jun 12, 2023
Key facts
| Document ID | FDA-2023-P-2347-0003 |
|---|---|
| Title | Attachment 1 Galliprant grapiprant Tablets re Suitability Petition from Aurora Pharmaceutical Inc |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2023-P-2347 |
| Posted | Jun 12, 2023 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: